CDT Equity Inc. Insider Trading
CDT
No open-market buying or selling by insiders.
No executive or director has bought shares on the open market in the last two years.
Get an email when CDT's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Aug 28 | Andrew Regan Chief Executive Officer | SoldNo plan | 29 | — | — | <0.1% | Form 4 |
| Jun 18 | Prospect Capital Securities Ltd Large holder | SoldNo plan 4 parts | 2,068,000 | $1.43 average | $2.95M | 100% | Form 4 |
- Aug 28No planAndrew ReganChief Executive Officer · sold 29—<0.1% of stake
- Jun 18No planProspect Capital Securities LtdLarge holder · sold 2,068,000 at avg $1.43$2.95M100% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with CDT
Spot a number that looks wrong? Check it in CDT's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing CDT
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.